Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Haoxi Health Technology (HAO) Shares Outstanding (2023 - 2025)

Haoxi Health Technology's Shares Outstanding history spans 2 years, with the latest figure at $2.2 million for Q2 2025.

  • Quarterly Shares Outstanding changed N/A to $2.2 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Jun 2025, changed N/A year-over-year, with the annual reading at $2.2 million for FY2025, N/A changed from the prior year.
  • Shares Outstanding came in at $2.2 million for Q2 2025, up from $1.2 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $2.2 million in Q2 2025 to a low of $1.2 million in Q2 2023.